Matthew B. Carroll, MD, FACP, FACR
Singing River Hospital System, USA
Matthew B. Carroll is a board certified Rheumatologist who is clinically active and currently employed by the Singing River Health System. He has had a passion for clinical research and has been an active member of the growing research team at his community hospital. He retired from the United States Air Force in 2017 but during his active duty service developed over 15 protocols and has published over 20 articles. A recent passion has been exploring the possible beneficial role of IL-6 blockade on acute myocardial infarction. He launched an ambitious protocol studying the short term effects on major adverse cardiac events which though it was eventually ended after futility analysis suggested no benefit, did enroll over 20 subjects and provided 180 day follow-up of data collection. He continues to actively lobby the study of IL-6 blockade in other areas of Cardiology.
Abstract : Tocilizumab in the treatment of acute myocardial infarction—A review of what we know with a look to the future